| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |